Hemorrhagic Cystitis Treatment in Singapore

Experiencing blood in your urine can be alarming and uncomfortable, especially when accompanied by painful urination and urgency. If you’re dealing with haemorrhagic cystitis, you’re not alone in seeking effective treatment to address this challenging bladder condition. At our urology clinic in Singapore, we understand the distress this condition causes and provide comprehensive care to help restore your bladder health and quality of life.

Haemorrhagic cystitis involves inflammation and bleeding of the bladder lining, requiring prompt medical attention and specialised treatment. Our MOH-accredited urologists utilise established diagnostic and treatment approaches to address both the symptoms and underlying causes of this condition, helping patients return to normal bladder function.

What is Haemorrhagic Cystitis?
Haemorrhagic cystitis is a condition characterised by inflammation of the bladder wall that leads to bleeding into the urine (haematuria). Unlike simple urinary tract infections, haemorrhagic cystitis involves damage to the bladder’s protective lining, causing blood vessels to become exposed and bleed. This results in visible blood in the urine, which can range from pink-tinged to bright red or contain blood clots.

The condition can be acute (sudden onset) or chronic (long-lasting), with severity ranging from mild bleeding to severe haemorrhage that requires immediate intervention. Common causes include radiation therapy to the pelvic area, chemotherapy medications (particularly cyclophosphamide and ifosfamide), viral infections, and certain bacterial infections. In some cases, the condition may develop without an identifiable cause.

Haemorrhagic cystitis differs from regular cystitis as it specifically involves bleeding, often requires more intensive treatment, and can lead to complications such as anaemia or bladder outlet obstruction from blood clots. Consulting a bladder specialist in Singapore can help ensure early diagnosis and appropriate treatment to prevent progression and manage symptoms effectively.

Ideal Candidates

• Patients experiencing visible blood in urine (gross haematuria)
• Individuals with painful urination accompanied by bleeding
• Those who have undergone pelvic radiation therapy
• Patients receiving or who have received chemotherapy medications
• People with frequent urination and bladder discomfort with bleeding
• Individuals with confirmed diagnosis through cystoscopy or imaging
• Patients with recurrent haemorrhagic episodes
• Those experiencing bladder spasms with haematuria

Contraindications

• Active untreated urinary tract obstruction
• Severe bleeding disorders without medical clearance
• Certain medications that increase bleeding risk (requires evaluation)
• Uncontrolled systemic infections
• Pregnancy (certain treatments may be contraindicated)
• Severe kidney dysfunction (affects treatment options)

The decision to proceed with specific treatments depends on individual factors including the underlying cause, severity of bleeding, and overall health status. Our urologists conduct thorough evaluations to determine the most appropriate treatment approach for each patient’s unique situation.

Conservative Management

For mild cases of haemorrhagic cystitis, conservative treatment focuses on supportive care and symptom management. This includes continuous bladder irrigation with saline solution to prevent clot formation, increased fluid intake to dilute urine and reduce irritation, and pain management medications. Patients are closely monitored for improvement, with most mild cases resolving within days to weeks with appropriate supportive care.

Intravesical Therapy

When conservative measures are insufficient, intravesical (directly into the bladder) treatments provide targeted therapy. Alum irrigation creates a protective coating on the bladder lining to reduce bleeding. Hyaluronic acid or chondroitin sulphate installations help restore the protective glycosaminoglycan layer of the bladder. Silver nitrate or formalin may be used in severe cases under careful supervision, though these require specialised handling and monitoring.

Endoscopic Interventions

Cystoscopy with fulguration allows direct visualisation and cauterisation of bleeding vessels within the bladder. This minimally invasive approach uses electrical or laser energy to seal bleeding points. For patients with significant blood clots, endoscopic clot evacuation provides immediate relief from obstruction and allows for better visualisation of the bladder lining. These procedures are typically performed under sedation or regional anaesthesia.

Technology & Equipment Used

Modern cystoscopes with high-definition imaging enable precise identification of bleeding sources. Laser systems provide controlled energy delivery for cauterisation. Continuous irrigation systems maintain bladder distension and visibility during procedures. Modern imaging including CT or MRI may be utilised to evaluate the extent of bladder involvement and rule out other pathology.

Pre-Treatment Preparation

Before initiating treatment, comprehensive evaluation includes urine analysis and culture to identify any infectious causes. Blood tests assess haemoglobin levels, kidney function, and clotting parameters. Imaging studies such as ultrasound or CT scan may be performed to evaluate the bladder and upper urinary tract. Patients are advised to increase fluid intake and may need to temporarily discontinue certain medications that affect bleeding.

Cystoscopy is often performed to directly visualise the bladder lining, assess the severity of inflammation, and identify specific bleeding sites. This diagnostic procedure also allows for tissue sampling if needed to rule out other conditions.

During the Procedure

For conservative management, patients receive continuous bladder irrigation through a specialised three-way catheter. The irrigation rate is adjusted based on urine colour and clot formation. Pain medications and antispasmodics help manage discomfort.

During intravesical therapy, medications are instilled directly into the bladder through a catheter. Patients typically retain the solution for 30-60 minutes before draining. The procedure is repeated according to the treatment protocol, often weekly initially.

Endoscopic procedures begin with careful bladder inspection. Bleeding vessels are systematically cauterised using electrical or laser energy. Large clots are evacuated using specialised instruments. The procedure typically takes 30-60 minutes depending on severity.

Immediate Post-Treatment

Following treatment, patients are monitored for urine output and colour. Continuous irrigation may continue until urine clears. Vital signs and haemoglobin levels are checked regularly. Pain management ensures comfort during recovery. Most patients with mild to moderate cases can return home the same day with appropriate instructions.

For those requiring more intensive intervention, short hospital stays allow for continuous monitoring and irrigation management. Catheter care instructions are provided, and follow-up appointments are scheduled to assess treatment response.

First 24-48 Hours

During the initial recovery period, patients should maintain high fluid intake (2-3 litres daily) to help flush the bladder. Urine colour is monitored for improvement from red to pink to clear. Mild bladder spasms and discomfort are normal and managed with prescribed medications. Any fever, severe pain, or inability to urinate requires immediate medical attention.

Activity is generally limited to light walking and rest. Heavy lifting and strenuous exercise should be avoided. If a catheter is in place, proper care prevents infection and ensures continuous drainage.

First Week

Gradual improvement in symptoms typically occurs during the first week. Urine should progressively clear, though some patients may experience intermittent mild bleeding. Follow-up appointments assess healing progress and need for continued treatment. Catheter removal timing depends on individual recovery.

Patients continue increased fluid intake and may require ongoing bladder antispasmodics. Any blood-thinning medications remain on hold until cleared by the urologist. Normal daily activities can usually resume, though strenuous activities are still restricted.

Long-term Recovery

Complete healing of the bladder lining may take several weeks to months depending on the initial severity. Regular follow-up appointments monitor for recurrence. Some patients require maintenance intravesical therapy to prevent recurrent episodes. Lifestyle modifications including adequate hydration and avoiding bladder irritants support long-term bladder health.

For radiation or chemotherapy-induced cases, ongoing monitoring is essential as symptoms may recur. Patients learn to recognise early warning signs and when to seek medical attention. Most achieve good long-term outcomes with appropriate treatment and follow-up care.

Effective treatment of haemorrhagic cystitis provides significant relief from distressing symptoms and prevents potential complications. Patients experience cessation of bleeding, reducing anxiety and improving quality of life. Resolution of painful urination and bladder spasms allows return to normal daily activities and better sleep quality.

Treatment prevents serious complications including severe anaemia from chronic blood loss, bladder outlet obstruction from blood clots, and potential kidney damage from untreated obstruction. Early intervention often results in faster recovery and reduces the likelihood of recurrent episodes.

Beyond symptom relief, proper treatment addresses underlying causes when possible, providing long-term bladder health benefits. Patients regain confidence in social and work situations without fear of visible bleeding or urgent bathroom needs. The psychological relief from resolving this alarming condition significantly improves overall well-being.

Common Side Effects

Temporary bladder irritation may occur following intravesical treatments, causing mild discomfort or urgency. This typically resolves within days. Catheter-related discomfort is common but manageable with medications. Some patients experience mild bladder spasms during the healing process.

Certain intravesical medications may cause temporary burning sensation during instillation. Mild fatigue is normal during recovery as the body heals. These effects are generally well-tolerated and resolve as treatment progresses.

Rare Complications

Serious complications are uncommon with proper treatment technique. Bladder perforation is a rare risk during endoscopic procedures, particularly in severely inflamed bladders. Infection risk exists with any bladder instrumentation but is minimised through sterile technique and appropriate antibiotics when indicated.

Allergic reactions to intravesical medications occur rarely. Severe bleeding requiring transfusion is uncommon but possible in severe cases. Bladder scarring or reduced capacity may develop in chronic severe cases, though this is preventable with timely treatment.

Our experienced urologists utilise careful technique and appropriate patient selection to minimise risks. Comprehensive pre-treatment evaluation and close monitoring during recovery help identify and address any complications promptly.

Treatment costs for haemorrhagic cystitis vary depending on the underlying cause, severity, and required interventions. Initial evaluation including consultation, diagnostic tests, and cystoscopy forms the baseline cost. Conservative management with medications and monitoring represents the most economical approach for mild cases.

Intravesical therapy costs depend on the specific medications used and number of treatments required. Endoscopic procedures involve facility fees, anaesthesia, and specialist fees. Hospital admission, when necessary, adds to overall treatment costs.

The investment in proper treatment prevents costly complications and reduces long-term healthcare needs. Our clinic provides transparent cost estimates during consultation, helping patients understand their financial commitment. Various payment options may be available to assist with treatment expenses.